Park Avenue Securities’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.59M | Buy |
18,193
+107
| +0.6% | +$9.34K | 0.01% | 598 |
|
2025
Q1 | $1.24M | Buy |
18,086
+4,739
| +36% | +$324K | 0.02% | 537 |
|
2024
Q4 | $1.04M | Buy |
13,347
+1,627
| +14% | +$127K | 0.01% | 743 |
|
2024
Q3 | $786K | Sell |
11,720
-2,990
| -20% | -$201K | 0.01% | 782 |
|
2024
Q2 | $1.67M | Sell |
14,710
-139
| -0.9% | -$15.8K | 0.02% | 475 |
|
2024
Q1 | $2.06M | Buy |
14,849
+2,123
| +17% | +$295K | 0.03% | 409 |
|
2023
Q4 | $1.58M | Sell |
12,726
-673
| -5% | -$83.5K | 0.02% | 446 |
|
2023
Q3 | $1.25M | Sell |
13,399
-3,516
| -21% | -$328K | 0.02% | 474 |
|
2023
Q2 | $2.17M | Sell |
16,915
-291
| -2% | -$37.4K | 0.03% | 299 |
|
2023
Q1 | $2M | Sell |
17,206
-392
| -2% | -$45.5K | 0.03% | 294 |
|
2022
Q4 | $1.99M | Buy |
17,598
+166
| +1% | +$18.8K | 0.04% | 310 |
|
2022
Q3 | $1.4M | Sell |
17,432
-1,000
| -5% | -$80.5K | 0.03% | 347 |
|
2022
Q2 | $1.37M | Buy |
18,432
+1,472
| +9% | +$110K | 0.03% | 363 |
|
2022
Q1 | $2.17M | Buy |
16,960
+2,424
| +17% | +$310K | 0.04% | 262 |
|
2021
Q4 | $1.95M | Buy |
14,536
+3,976
| +38% | +$534K | 0.03% | 283 |
|
2021
Q3 | $1.44M | Buy |
10,560
+932
| +10% | +$127K | 0.03% | 302 |
|
2021
Q2 | $1.03M | Buy |
9,628
+2,696
| +39% | +$288K | 0.02% | 377 |
|
2021
Q1 | $623K | Buy |
6,932
+3,260
| +89% | +$293K | 0.02% | 514 |
|
2020
Q4 | $339K | Buy |
+3,672
| New | +$339K | 0.01% | 633 |
|